Daunoblastin en es it fr

Daunoblastin Brand names, Daunoblastin Analogs

Daunoblastin Brand Names Mixture

  • No information avaliable

Daunoblastin Chemical_Formula

C27H29NO10

Daunoblastin RX_link

http://www.rxlist.com/cgi/generic2/daunorubicin.htm

Daunoblastin fda sheet

http://www.accessdata.fda.gov/scripts/cder/onctools/labels.cfm?GN=daunorubicin,%20daunomycin

Daunoblastin msds (material safety sheet)

Daunoblastin MSDS

Daunoblastin Synthesis Reference

J. P. Parsh et al. J. Pharm. Sci. 56, 1691 (1967);

Daunoblastin Molecular Weight

527.52 g/mol

Daunoblastin Melting Point

208-209 oC

Daunoblastin H2O Solubility

39.2 mg/L

Daunoblastin State

Solid

Daunoblastin LogP

0.766

Daunoblastin Dosage Forms

Powder for solution; Suspension

Daunoblastin Indication

For remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.

Daunoblastin Pharmacology

Daunorubicin is an antineoplastic in the anthracycline class. General properties of drugs in this class include: interaction with DNA in a variety of different ways including intercalation (squeezing between the base pairs), DNA strand breakage and inhibition with the enzyme topoisomerase II. Most of these compounds have been isolated from natural sources and antibiotics. However, they lack the specificity of the antimicrobial antibiotics and thus produce significant toxicity. The anthracyclines are among the most important antitumor drugs available. Doxorubicin is widely used for the treatment of several solid tumors while daunorubicin and idarubicin are used exclusively for the treatment of leukemia. Daunorubicin may also inhibit polymerase activity, affect regulation of gene expression, and produce free radical damage to DNA. Daunorubicin possesses an antitumor effect against a wide spectrum of tumors, either grafted or spontaneous. The anthracyclines are cell cycle-nonspecific.

Daunoblastin Absorption

No information avaliable

Daunoblastin side effects and Toxicity

LD50=20 mg/kg (mice, IV); LD50=13 mg/kg (rat, IV)

Daunoblastin Patient Information

Daunoblastin Organisms Affected

Humans and other mammals